Park National Corp Astrazeneca PLC Transaction History

Park National Corp

  • $3.02 Billion
  • Q3 2025

A detailed history of Park National Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Park National Corp holds 159,599 shares of AZN stock, worth $14.3 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
159,599
Previous 149,203 6.97%
Holding current value
$14.3 Million
Previous $10.4 Million 17.44%
% of portfolio
0.41%
Previous 0.36%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 01, 2025
BUY
$68.72 - $82.11 $714,413 - $853,615
10,396 Added 6.97%
159,599 $12.2 Million
Q2 2025

Jul 01, 2025
BUY
$64.87 - $75.0 $95,877 - $110,850
1,478 Added 1.0%
149,203 $10.4 Million
Q1 2025

Apr 02, 2025
SELL
$65.37 - $77.96 $418,825 - $499,489
-6,407 Reduced 4.16%
147,725 $10.9 Million
Q4 2024

Jan 08, 2025
BUY
$63.2 - $79.58 $57,575 - $72,497
911 Added 0.59%
154,132 $10.1 Million
Q3 2024

Oct 01, 2024
SELL
$76.67 - $87.62 $625,703 - $715,066
-8,161 Reduced 5.06%
153,221 $11.9 Million
Q2 2024

Jul 15, 2024
BUY
$66.81 - $80.83 $1.3 Million - $1.58 Million
19,499 Added 13.74%
161,382 $12.6 Million
Q1 2024

Apr 01, 2024
SELL
$61.03 - $69.57 $260,170 - $296,576
-4,263 Reduced 2.92%
141,883 $9.61 Million
Q4 2023

Jan 02, 2024
BUY
$61.89 - $69.28 $445,360 - $498,538
7,196 Added 5.18%
146,146 $9.84 Million
Q3 2023

Oct 02, 2023
SELL
$64.85 - $71.7 $116,794 - $129,131
-1,801 Reduced 1.28%
138,950 $9.41 Million
Q2 2023

Jul 03, 2023
SELL
$69.91 - $75.81 $571,024 - $619,216
-8,168 Reduced 5.48%
140,751 $10.1 Million
Q1 2023

Apr 03, 2023
SELL
$63.15 - $71.6 $119,100 - $135,037
-1,886 Reduced 1.25%
148,919 $10.3 Million
Q4 2022

Feb 06, 2023
BUY
$54.21 - $70.44 $3.8 Million - $4.93 Million
70,057 Added 86.76%
150,805 $10.2 Million
Q3 2022

Oct 03, 2022
SELL
$53.02 - $135.75 $56,625 - $144,981
-1,068 Reduced 1.31%
80,748 $4.43 Million
Q2 2022

Jul 01, 2022
SELL
$59.26 - $71.14 $838,766 - $1.01 Million
-14,154 Reduced 14.75%
81,816 $5.41 Million
Q1 2022

Apr 01, 2022
SELL
$55.72 - $67.12 $761,915 - $917,798
-13,674 Reduced 12.47%
95,970 $6.37 Million
Q4 2021

Jan 04, 2022
SELL
$54.02 - $63.83 $1.38 Million - $1.63 Million
-25,588 Reduced 18.92%
109,644 $6.39 Million
Q3 2021

Oct 01, 2021
SELL
$55.56 - $60.79 $1.73 Million - $1.89 Million
-31,151 Reduced 18.72%
135,232 $8.12 Million
Q2 2021

Jul 01, 2021
SELL
$48.42 - $60.18 $6.95 Million - $8.64 Million
-143,512 Reduced 46.31%
166,383 $9.97 Million
Q1 2021

Apr 01, 2021
BUY
$47.16 - $54.44 $28,814 - $33,262
611 Added 0.2%
309,895 $15.4 Million
Q4 2020

Jan 04, 2021
BUY
$48.52 - $58.02 $307,859 - $368,136
6,345 Added 2.09%
309,284 $15.5 Million
Q3 2020

Oct 01, 2020
SELL
$53.07 - $61.1 $115,480 - $132,953
-2,176 Reduced 0.71%
302,939 $16.6 Million
Q2 2020

Jul 01, 2020
SELL
$43.1 - $55.31 $546,249 - $700,998
-12,674 Reduced 3.99%
305,115 $16.1 Million
Q1 2020

Apr 01, 2020
BUY
$37.79 - $51.33 $113,899 - $154,708
3,014 Added 0.96%
317,789 $14.2 Million
Q4 2019

Jan 02, 2020
BUY
$42.46 - $50.46 $427,911 - $508,535
10,078 Added 3.31%
314,775 $15.7 Million
Q3 2019

Oct 01, 2019
BUY
$40.12 - $45.47 $1.06 Million - $1.2 Million
26,426 Added 9.5%
304,697 $13.6 Million
Q2 2019

Jul 01, 2019
BUY
$37.28 - $41.68 $1.51 Million - $1.68 Million
40,391 Added 16.98%
278,271 $11.5 Million
Q1 2019

Apr 01, 2019
BUY
$35.49 - $43.02 $2.21 Million - $2.68 Million
62,399 Added 35.56%
237,880 $9.62 Million
Q4 2018

Jan 02, 2019
BUY
$36.86 - $41.49 $3.69 Million - $4.15 Million
100,111 Added 132.83%
175,481 $6.67 Million
Q3 2018

Oct 02, 2018
BUY
$34.76 - $39.72 $2.62 Million - $2.99 Million
75,370 New
75,370 $2.98 Million

Others Institutions Holding AZN

# of Institutions
1,498
Shares Held
500M
Call Options Held
5.59M
Put Options Held
3.18M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Park National Corp Portfolio

Follow Park National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email